| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 606 |
| 1 | INSULIN LISPRO | 273 |
| 2 | INSULIN HUMAN | 61 |
| 3 | INSULIN GLARGINE | 53 |
| 4 | LEUPROLIDE ACETATE | 30 |
| 5 | DULAGLUTIDE | 25 |
| 6 | METFORMIN | 25 |
| 7 | METFORMIN ER 500 MG | 25 |
| 8 | METFORMIN ER 750 MG | 25 |
| 9 | GALCANEZUMAB-GNLM | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | 1 | 0.3333 |
| 1 | DEXTROSE AND POTASSIUM CHLORIDE | 2 | 0.1176 |
| 2 | SODIUM CHLORIDE FOR IRRIGATION | 1 | 0.0714 |
| 3 | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0417 |
| 4 | LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE | 1 | 0.0400 |
| 5 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 2 | 0.0333 |
| 6 | CEFTAZIDIME, AVIBACTAM | 2 | 0.0118 |
| 7 | AXATILIMAB-CSFR | 1 | 0.0061 |
| 8 | SODIUM ACETATE | 1 | 0.0035 |
| 9 | TIRZEPATIDE | 606 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 633 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 606 |
| 2 | Insulin Analog [EPC] | 286 |
| 3 | Insulin [EPC] | 63 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 15 |
| 5 | Corticosteroid [EPC] | 12 |
| 6 | Benzodiazepine [EPC] | 10 |
| 7 | Leukocyte Growth Factor [EPC] | 9 |
| 8 | Factor Xa Inhibitor [EPC] | 7 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 1 | GLP-1 Receptor Agonist [EPC] | 633 | 0.0014 |
| 2 | Insulin [EPC] | 63 | 0.0014 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 5 | Oxytocic [EPC] | 3 | 0.0010 |
| 6 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 7 | Insulin Analog [EPC] | 286 | 0.0006 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |